The clinical trial enrollment process: what happens next?
Clinical trial enrollment involves information, eligibility assessment and consent, but the sequence depends on the study. A first enquiry does not enroll you, and research-specific screening may itself need consent. Ask the team which stage you are at, what happens next and what decision you are being asked to make.
See the possible pathwayhttps://www.hopestage.com/research/learn/clinical-trial-enrollment-process
Key takeaways
- Distinguish an initial enquiry from research screening and enrollment.
- Ask about consent before any research-specific procedures.
- Keep a clear next step and contact after every conversation.
On this page
Find a study and verify the contact
Check the official study record, identifier, current recruitment and local site. Read what participants actually do before contacting the team. Save the source and use a verified contact, particularly before sharing sensitive information. A recruiting label helps you find a lead; it does not confirm a place or your eligibility.
Understand first contact and research screening
A team may first ask basic questions about possible fit. Ask whether the conversation is preliminary or part of research screening. FDA guidance distinguishes initial discussion from procedures performed solely to determine research eligibility, which require prior informed consent. Ask what information is needed and how it should be shared securely.
The FDA source describes the US regulatory setting. In another country, ask the local team which approved consent and screening arrangements apply. A routine clinical test and a test done solely for research eligibility are different situations. Never change psychiatric medication to qualify; any proposed clinical change needs discussion with the responsible clinicians.
Clarify consent, participation and follow-up
Request the participant information and ask how the consent discussion fits the actual schedule. You may need to understand different stages or documents. Ask what signing each document permits and what remains undecided. If you continue, keep copies, the visit plan and the contact for questions.
A possible pathway, with decisions along the way
These are milestones to clarify with the team, not a universal appointment order. Some studies have separate screening and main-study consent discussions. The required information and consent come before the research procedures they cover.
Enquiry and preliminary questions
Verify the study and ask what information is needed. This first conversation does not enroll you.
Information and the relevant consent
Understand the proposed activities, risks, alternatives and privacy arrangements. Ask which procedures this agreement covers.
Research screening, if you choose to proceed
The team carries out the agreed checks under the study’s approved process. A screening result does not guarantee enrollment.
A decision and a confirmed next step
The team confirms whether the criteria and available place permit inclusion. You can decline; ask what care or follow-up is needed either way.
Discuss care and practical arrangements before deciding
Ask about visit length, travel, home tasks, costs and reimbursement. If the study proposes treatment changes, discuss them with your treating clinician and ask who coordinates care. Do not change medication or routines to qualify on the basis of a listing. Bring a supporter to the discussion if you want, subject to the team’s arrangements.
Plan for either outcome after screening
Ask what happens if you are not eligible or choose not to continue, especially after any research-related procedure or agreed care change. Clarify whether follow-up is proposed and who receives relevant information. If you do join, ask how to raise concerns or discuss leaving later.
Questions to resolve before the next stage
- Have I matched the invitation to the official record and verified the contact?
- Is this preliminary contact, research screening or a participation decision?
- Have I received information, asked questions and given any consent required before the proposed research procedure?
- What assessments remain, and who confirms eligibility and any available place?
- What are the agreed visits, risks, costs, possible payments, privacy arrangements and withdrawal contacts?
- What happens to my care and follow-up if I decline or am not eligible?
Questions and answers
Does screening mean I am enrolled?
Not necessarily. Ask the team what screening involves and what still needs to happen before enrollment is confirmed.
Does consent always happen after screening?
No. Research-specific screening procedures may require consent first. Ask which discussions and documents apply at each stage.
Who confirms eligibility?
The research team assesses the study criteria. A public listing or a completed enquiry cannot confirm eligibility.
Can I decide not to continue?
Participation is voluntary. Ask about the next care steps and any proposed follow-up if you stop screening or decide against joining.
Explore the current directory
Ready to explore? Use a public record to find a verified contact. A listing, enquiry or screening appointment does not confirm a place.
Find studies to explore
